We previously showed that mucosal spike IgA levels remained elevated for up to seven months following omicron infection in triple-vaccinated healthcare workers in our cohort,26 and we have demonstrated that also low levels of mucosal spike IgA are associated with protection against omicron BA.1/2 and BQ infections.26 This evidence concerns the gene CD79A and infection.